Despite the fact that ethanol is the most widely used drug and an important macronutrient, there is little information in women with respect to ethanol's nutritional value and its interactions with other macronutrients. This study was designed to test the hypotheses that in healthy women ethanol in moderate amounts 1) contains no """"""""empty calories"""""""" but is a preferred fuel replacing fat CHO and protein as substrates for oxidation, 2) causes acute resistance to actions of insulin on CHO and fat metabolism and 3) causes deterioration of glucose tolerance in elderly women because they are unable to overcome the ethanol induced insulin resistance by over-secretion of insulin. We will test these hypotheses 1) by determining interaction of ethanol with the oxidation of other metabolic fuels (with indirect calorimetry); 2) by comparing effects of ethanol on insulin sensitivity (determined with euglycemic- hyperinsulinemic clamps) and on glucose tolerance (determined during IV glucose infusions) in young and elderly healthy women who drink alcohol rarely or not at all and in young and elderly women who habitually drink alcohol in moderate amounts. To explore possible mechanisms for ethanol induced insulin resistance, we will study effect of ethanol on intracellular pathways of CHO and fat metabolism. Measurements will include: in vivo rates of glucose uptake, glycolysis (both with 3-3H glucose), glycogen synthesis (glucose uptake minus glycolysis), non-oxidative glycolysis (glycolysis minus CHO oxidation), lipolysis (with 2H glycerol), fatty acid reesterification (with 2H5 glycerol and I-13C palmitate), CHO, fat and protei oxidation (with indirect calorimetry). Activities of pyruvate dehydrogenase and glycogen synthase and conc. of acetyl-CoA, CoA-SH, G-6-P, UDPG, lactate, pyruvate, glucose and citrate will b measured in muscle biopsies. To determine which effects are caused by ethanol or acetal-dehyde and which by acetate or its metabolites, we will perform all measurements during infusions wit acetate as well as with ethanol. We hope that these studies will provide important information on the nutritional impact of ethanol and on its possible contributory role to the development of atherosclerotic vascular disease and diabetes in women.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
1R01AA010221-01
Application #
2046764
Study Section
Special Emphasis Panel (SRCA (50))
Project Start
1995-01-01
Project End
1997-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Temple University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Boden, Guenther; Cheung, Peter; Mozzoli, Maria et al. (2003) Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 52:753-9
Boden, G; Lebed, B; Schatz, M et al. (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612-7
Boden, G (2001) Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 7:44-51
Boden, G; Chen, X; Capulong, E et al. (2001) Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50:810-6
Boden, G; Chen, X; Stein, T P (2001) Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280:E23-30
Iqbal, N; Zayed, M; Boden, G (2000) Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetes. Diabetes Care 23:1172-6
Sinha, D; Addya, S; Murer, E et al. (1999) 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene. Metabolism 48:786-91
Rao, A K; Chouhan, V; Chen, X et al. (1999) Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 48:1156-61
Boden, G (1999) Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians 111:241-8
Rane, S G; Dubus, P; Mettus, R V et al. (1999) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 22:44-52

Showing the most recent 10 out of 31 publications